[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE8703854D0 - Prostaglandinderivat for behandling av glaukom eller okuler hypertension - Google Patents

Prostaglandinderivat for behandling av glaukom eller okuler hypertension

Info

Publication number
SE8703854D0
SE8703854D0 SE8703854A SE8703854A SE8703854D0 SE 8703854 D0 SE8703854 D0 SE 8703854D0 SE 8703854 A SE8703854 A SE 8703854A SE 8703854 A SE8703854 A SE 8703854A SE 8703854 D0 SE8703854 D0 SE 8703854D0
Authority
SE
Sweden
Prior art keywords
treatment
glaucome
prostagland
ingredients
ocular hypertension
Prior art date
Application number
SE8703854A
Other languages
English (en)
Swedish (sv)
Inventor
J W Stjernschantz
B Resul
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8703854A priority Critical patent/SE8703854D0/xx
Publication of SE8703854D0 publication Critical patent/SE8703854D0/xx
Priority to AT88908778T priority patent/ATE78031T1/de
Priority to EP88908778A priority patent/EP0344235B1/en
Priority to PCT/SE1988/000515 priority patent/WO1989003384A1/en
Priority to JP63508064A priority patent/JP2852057B2/ja
Priority to DE8888908778T priority patent/DE3872701T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
SE8703854A 1987-10-07 1987-10-07 Prostaglandinderivat for behandling av glaukom eller okuler hypertension SE8703854D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE8703854A SE8703854D0 (sv) 1987-10-07 1987-10-07 Prostaglandinderivat for behandling av glaukom eller okuler hypertension
AT88908778T ATE78031T1 (de) 1987-10-07 1988-10-06 Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
EP88908778A EP0344235B1 (en) 1987-10-07 1988-10-06 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
PCT/SE1988/000515 WO1989003384A1 (en) 1987-10-07 1988-10-06 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
JP63508064A JP2852057B2 (ja) 1987-10-07 1988-10-06 緑内症または高眼圧症治療剤
DE8888908778T DE3872701T2 (de) 1987-10-07 1988-10-06 Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8703854A SE8703854D0 (sv) 1987-10-07 1987-10-07 Prostaglandinderivat for behandling av glaukom eller okuler hypertension

Publications (1)

Publication Number Publication Date
SE8703854D0 true SE8703854D0 (sv) 1987-10-07

Family

ID=20369771

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703854A SE8703854D0 (sv) 1987-10-07 1987-10-07 Prostaglandinderivat for behandling av glaukom eller okuler hypertension

Country Status (6)

Country Link
EP (1) EP0344235B1 (ja)
JP (1) JP2852057B2 (ja)
AT (1) ATE78031T1 (ja)
DE (1) DE3872701T2 (ja)
SE (1) SE8703854D0 (ja)
WO (1) WO1989003384A1 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2021316C (en) * 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5011856A (en) * 1990-03-12 1991-04-30 Allergan, Inc. Use of prostaglandin F3 α as an ocular hypotensive agent
EP0521009A4 (en) * 1990-03-19 1993-02-24 Allergan, Inc. Use of 5-trans prostaglandin f 2-g(a)? as an ocular hypotensive agent
US5238961A (en) * 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives
DE4036140A1 (de) * 1990-11-09 1992-05-14 Schering Ag 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US6124353A (en) * 1992-11-12 2000-09-26 Allergan Sales, Inc. Method of treating ocular hypertension with 8-epi prostaglandins
KR950000664A (ko) * 1993-06-14 1995-01-03 우에노 도시오 신규한 13,14-디히드로-피지에프 2 베타(PGF2β) 및 이의 이소프로필 에스테르
JP4397973B2 (ja) 1997-02-04 2010-01-13 ジョンストン， マーレイ エイ． 瞼の毛髪の成長を刺激するための局所的組成物
WO2000051980A1 (en) 1999-03-05 2000-09-08 The Procter & Gamble Company C16 unsaturated fp-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
RU2567792C2 (ru) 2009-11-09 2015-11-10 Аллерган, Инк. Композиции и способы стимулирования роста волос
US10272040B2 (en) 2010-08-12 2019-04-30 Nanyang Technological University Liposomal formulation for ocular drug delivery
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE391714B (sv) * 1970-09-11 1977-02-28 Upjohn Co Forfarande for framstellning av prostaglandiner av typ pge?712 med foreningar av typ pga?712 som utgangsforeningar
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma

Also Published As

Publication number Publication date
WO1989003384A1 (en) 1989-04-20
EP0344235A1 (en) 1989-12-06
ATE78031T1 (de) 1992-07-15
EP0344235B1 (en) 1992-07-08
JP2852057B2 (ja) 1999-01-27
JPH02501483A (ja) 1990-05-24
DE3872701T2 (de) 1992-12-03
DE3872701D1 (de) 1992-08-13

Similar Documents

Publication Publication Date Title
SE8703854D0 (sv) Prostaglandinderivat for behandling av glaukom eller okuler hypertension
ES2186670T3 (es) Derivados de prostaglandina para el tratamiento del glaucoma o la hipertension ocular.
ES2051479T3 (es) Uso de imidazoles substituidos en 4 para disminuir la presion intraocular.
NO166281C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater.
ES2079872T3 (es) Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
FI892222A (fi) Peptidalkoholer med antikoagulantverkan.
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
ES2054011T3 (es) Un proceso para la preparacion de un compuesto, "leualacina".
DK0378146T3 (da) Polyamin-derivater som antineoplastiske midler
EP1300151A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
KR890005107A (ko) 약제 제조를 위한 특정 6-머캅토푸린의 용도 및 이 약제의 제조방법
NO903585D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.
ES2038702T3 (es) Un procedimiento para preparar derivados triazolopirimidina triciclicos.
ATE88636T1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augenhypertension und glaukom.
SE8202433L (sv) Linkomycin-3-(5'-ribonukleotider)lempade for behandling av protosoriska sjukdomar
PT91816A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de prostaglandinas para tratamento de glaucoma ou hipertensao ocular
HK159095A (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
AU625096C (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
NO901987D0 (no) Prostaglandinderivater for behandling av glaukom eller okular hypertensjon.